Patient satisfaction survey of the “Healthy Heart” pharmaceutical care service – evaluation of pharmacy labelling with pharmaceutical pictograms

[1]  A. Greco,et al.  How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology (EAPC). , 2022, European journal of preventive cardiology.

[2]  J. Dorszewska,et al.  Costs of Stroke and Incidence of First Diagnosis of Atrial Fibrillation at Time of Stroke. Neurology Ward Hospital Poznań, Poland 2018 , 2021, Healthcare.

[3]  J. Krysiński,et al.  Patient counselling service with the use of pictograms as the example of pharmacist intervention to improving compliance and medicine safety , 2021, Cardiology journal.

[4]  M. Niewada,et al.  Economic Costs of Cardiovascular Diseases in Poland Estimates for 2015–2017 Years , 2020, Frontiers in Pharmacology.

[5]  H. Sletvold,et al.  Impact of pictograms on medication adherence: A systematic literature review. , 2019, Patient education and counseling.

[6]  D. King,et al.  Estimated societal costs of stroke in the UK based on a discrete event simulation , 2019, Age and ageing.

[7]  N. Wong,et al.  Epidemiology of Diabetes Mellitus and Cardiovascular Disease , 2019, Current Cardiology Reports.

[8]  A. Galinsky,et al.  Making medications stick: improving medication adherence by highlighting the personal health costs of non-compliance , 2019, Behavioural Public Policy.

[9]  J. Pell,et al.  Adherence to cardiovascular medication: a review of systematic reviews , 2018, Journal of public health.

[10]  Andreas Luft,et al.  Global Burden of Stroke , 2018, Seminars in Neurology.

[11]  Fernando Fernandez-Llimos,et al.  Economic impact of medication non-adherence by disease groups: a systematic review , 2018, BMJ Open.

[12]  L. Sharp,et al.  Real‐World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation , 2017, Pharmacotherapy.

[13]  Jieli Chen,et al.  Brain–Heart Interaction: Cardiac Complications After Stroke , 2017, Circulation research.

[14]  J. Hanlon,et al.  Improving Medication Adherence and Health Outcomes in Older Adults: An Evidence-Based Review of Randomized Controlled Trials , 2017, Drugs & Aging.

[15]  M. Jaguszewski,et al.  Pharmaceutical services as a tool to improve outcomes in patients with cardiovascular diseases. , 2016, International journal of cardiology.

[16]  Jun Zhu,et al.  Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study , 2016, The Lancet.

[17]  Yu Heng Kwan,et al.  Medication adherence in the elderly , 2016 .

[18]  S. Mathew,et al.  Medication Adherence: Truth and Consequences☆ , 2016, The American journal of the medical sciences.

[19]  M. Walsh,et al.  The role of the clinical pharmacist in the care of patients with cardiovascular disease. , 2015, Journal of the American College of Cardiology.

[20]  Alessandro Monaco,et al.  Interventional tools to improve medication adherence: review of literature , 2015, Patient preference and adherence.

[21]  M. Bouvy,et al.  From "retailers" to health care providers: Transforming the role of community pharmacists in chronic disease management. , 2015, Health policy.

[22]  Ellen Uiters,et al.  Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU) , 2015, European journal of public health.

[23]  Gustavo Saposnik,et al.  Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis , 2015, The Lancet Neurology.

[24]  Deepak L. Bhatt,et al.  Non-adherence to cardiovascular medications. , 2014, European heart journal.

[25]  Mårten Rosenqvist,et al.  High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke , 2014, Stroke.

[26]  E. Russo,et al.  Adherence to therapy and adverse drug reactions: is there a link? , 2014, Expert opinion on drug safety.

[27]  M. Hassali,et al.  Modified labels for long-term medications: influences on adherence, comprehension and preferences in Malaysia , 2014, International Journal of Clinical Pharmacy.

[28]  G. Grunwald,et al.  Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration. , 2014, American heart journal.

[29]  Samuel S. Allemann,et al.  Pharmaceutical Care: the PCNE definition 2013 , 2014, International Journal of Clinical Pharmacy.

[30]  J. Cha,et al.  Two-Year Direct Medical Costs of Stroke in Korea: A Multi-Centre Incidence-Based Study from Hospital Perspectives , 2013, International journal of stroke : official journal of the International Stroke Society.

[31]  J. Wiebe,et al.  Medication literacy in Spanish and English: psychometric evaluation of a new assessment tool. , 2012, Journal of the American Pharmacists Association : JAPhA.

[32]  Andrew Steptoe,et al.  Association between low functional health literacy and mortality in older adults: longitudinal cohort study , 2012, BMJ : British Medical Journal.

[33]  T. Chen,et al.  Targeting Suboptimal Prescribing in the Elderly: A Review of the Impact of Pharmacy Services , 2009, The Annals of pharmacotherapy.

[34]  J. D. Sutton,et al.  Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit. , 1994, Hospital pharmacy.

[35]  J. W. F. Mil.  Definitions of Pharmaceutical Care and Related Concepts , 2019 .

[36]  Alan H S Chan,et al.  Comprehension by older people of medication information with or without supplementary pharmaceutical pictograms. , 2017, Applied ergonomics.

[37]  M. McGuire,et al.  Adherence and health care costs , 2014 .

[38]  KjellAsplund,et al.  High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke , 2014 .

[39]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..